The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 6
  • 1
    Rigby, Alan
    Director born in May 1965
    Individual (1 offspring)
    Officer
    2023-12-22 ~ now
    OF - Director → CIF 0
  • 2
    Rulleau, Laurence
    Director born in May 1964
    Individual (1 offspring)
    Officer
    2021-11-30 ~ now
    OF - Director → CIF 0
  • 3
    Pesant, Maxime
    Director born in June 1982
    Individual (1 offspring)
    Officer
    2021-12-07 ~ now
    OF - Director → CIF 0
  • 4
    Anstey, Michael Leith
    Venture Capital Investor born in September 1980
    Individual (6 offsprings)
    Officer
    2021-11-30 ~ now
    OF - Director → CIF 0
  • 5
    Perreault, Claude Wilfrid, Dr
    Director born in April 1952
    Individual (1 offspring)
    Officer
    2024-07-18 ~ now
    OF - Director → CIF 0
  • 6
    Jindal, Satish, Dr
    Venture Capitalist born in November 1955
    Individual (2 offsprings)
    Officer
    2023-03-14 ~ now
    OF - Director → CIF 0
Ceased 3
  • 1
    Moore, Jonathan David, Dr
    Biotechnology Executive born in April 1967
    Individual (3 offsprings)
    Officer
    2021-04-23 ~ 2023-12-22
    OF - Director → CIF 0
    Dr Jonathan David Moore
    Born in April 1967
    Individual (3 offsprings)
    Person with significant control
    2021-04-23 ~ 2021-11-30
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
  • 2
    Parekh, Rajesh Bhikhu, Dr
    Director born in July 1960
    Individual (18 offsprings)
    Officer
    2021-11-30 ~ 2023-03-13
    OF - Director → CIF 0
  • 3
    ADVENT LIFE SCIENCE PARTNERS LLP - 2011-07-08
    ADVENT VENTURES LIFE SCIENCES LLP - 2011-05-05
    27, Fitzroy Square, London, England
    Active Corporate (22 parents, 16 offsprings)
    Person with significant control
    2021-11-30 ~ 2024-07-18
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
parent relation
Company in focus

EPITOPEA LIMITED

Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Comprehensive Income/Expense
3,555,416 GBP2022-05-01 ~ 2023-04-30
2,151,828 GBP2021-04-23 ~ 2022-04-30
Equity
Called up share capital
1,650 GBP2023-04-30
2,022 GBP2022-04-30
Other miscellaneous reserve
107,192 GBP2023-04-30
0 GBP2022-04-30
Retained earnings (accumulated losses)
5,707,244 GBP2023-04-30
3,227,742 GBP2022-04-30
Equity
0 GBP2023-04-30
3,225,720 GBP2022-04-30
Average Number of Employees
72022-05-01 ~ 2023-04-30
22021-04-23 ~ 2022-04-30
Cash and Cash Equivalents
753,020 GBP2023-04-30
810,831 GBP2022-04-30
Current Assets
1,288,779 GBP2023-04-30
1,155,343 GBP2022-04-30
Total assets
1,317,913 GBP2023-04-30
1,159,478 GBP2022-04-30
Total Borrowings
Current
4,020,999 GBP2023-04-30
2,186,845 GBP2022-04-30
Total liabilities
4,117,114 GBP2023-04-30
2,234,718 GBP2022-04-30
Net Assets/Liabilities
-2,799,201 GBP2023-04-30
-1,075,240 GBP2022-04-30
Profit/Loss
Retained earnings (accumulated losses)
-1,777,708 GBP2022-05-01 ~ 2023-04-30
-1,075,914 GBP2021-04-23 ~ 2022-04-30
Profit/Loss
-1,777,708 GBP2022-05-01 ~ 2023-04-30
-1,075,914 GBP2021-04-23 ~ 2022-04-30
Comprehensive Income/Expense
Retained earnings (accumulated losses)
-1,777,708 GBP2022-05-01 ~ 2023-04-30
-1,075,914 GBP2021-04-23 ~ 2022-04-30
Issue of Equity Instruments
Called up share capital
151 GBP2022-05-01 ~ 2023-04-30
674 GBP2021-04-23 ~ 2022-04-30
Issue of Equity Instruments
151 GBP2022-05-01 ~ 2023-04-30
674 GBP2021-04-23 ~ 2022-04-30
Equity - Income/Expense Recognised Directly
Called up share capital
151 GBP2022-05-01 ~ 2023-04-30
674 GBP2021-04-23 ~ 2022-04-30
Equity - Income/Expense Recognised Directly
53,747 GBP2022-05-01 ~ 2023-04-30
674 GBP2021-04-23 ~ 2022-04-30
Property, Plant & Equipment - Depreciation Expense
7,026 GBP2022-05-01 ~ 2023-04-30
470 GBP2021-04-23 ~ 2022-04-30
Wages/Salaries
610,477 GBP2022-05-01 ~ 2023-04-30
81,951 GBP2021-04-23 ~ 2022-04-30
Social Security Costs
41,501 GBP2022-05-01 ~ 2023-04-30
425 GBP2021-04-23 ~ 2022-04-30
Staff Costs/Employee Benefits Expense
700,184 GBP2022-05-01 ~ 2023-04-30
90,270 GBP2021-04-23 ~ 2022-04-30
Director Remuneration
236,925 GBP2022-05-01 ~ 2023-04-30
66,903 GBP2021-04-23 ~ 2022-04-30
Current Tax for the Period
-366,151 GBP2022-05-01 ~ 2023-04-30
-179,024 GBP2021-04-23 ~ 2022-04-30
Tax Expense/Credit at Applicable Tax Rate
-407,333 GBP2022-05-01 ~ 2023-04-30
-238,438 GBP2021-04-23 ~ 2022-04-30
Property, Plant & Equipment - Gross Cost
Computers
13,563 GBP2023-04-30
4,605 GBP2022-04-30
Property, Plant & Equipment - Gross Cost
36,630 GBP2023-04-30
4,605 GBP2022-04-30
Other
23,067 GBP2023-04-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Computers
3,950 GBP2022-05-01 ~ 2023-04-30
470 GBP2021-04-23 ~ 2022-04-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
7,026 GBP2022-05-01 ~ 2023-04-30
470 GBP2021-04-23 ~ 2022-04-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Computers
4,420 GBP2023-04-30
470 GBP2022-04-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
7,496 GBP2023-04-30
470 GBP2022-04-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Other
3,076 GBP2022-05-01 ~ 2023-04-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Other
3,076 GBP2023-04-30
Prepayments/Accrued Income
Current
74,522 GBP2023-04-30
60,866 GBP2022-04-30
Amount of corporation tax that is recoverable
Current
366,151 GBP2023-04-30
179,024 GBP2022-04-30
Trade Creditors/Trade Payables
Current
46,912 GBP2023-04-30
23,536 GBP2022-04-30
Accrued Liabilities
Current
26,101 GBP2023-04-30
17,028 GBP2022-04-30
Taxation/Social Security Payable
Current
15,465 GBP2023-04-30
4,242 GBP2022-04-30
Total Borrowings
4,020,999 GBP2023-04-30
2,186,845 GBP2022-04-30
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
1,637,500 shares2023-04-30
1,637,500 shares2022-04-30
Class 2 ordinary share
6,609,250 shares2023-04-30
5,101,000 shares2022-04-30
  • EPITOPEA LIMITED
    Info
    Registered number 13354764
    Salisbury House, Station Road, Cambridge, Cambridgeshire CB1 2LA
    Private Limited Company incorporated on 2021-04-23 (4 years 2 months). The company status is Active.
    The last date of confirmation statement was made at 2024-04-22
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy policy

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.